{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:24:26Z","timestamp":1773152666393,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T00:00:00Z","timestamp":1190073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1007\/s12016-007-0038-3","type":"journal-article","created":{"date-parts":[[2007,9,17]],"date-time":"2007-09-17T16:02:40Z","timestamp":1190044960000},"page":"134-143","source":"Crossref","is-referenced-by-count":65,"title":["Chronic Urticaria: Recent Advances"],"prefix":"10.1007","volume":"33","author":[{"given":"Malcolm W.","family":"Greaves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kian Teo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,18]]},"reference":[{"key":"38_CR1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0021-8707(54)90034-9","volume":"25","author":"JM Sheldon","year":"1954","unstructured":"Sheldon JM, Mathews KP, Lovell RG (1954) The vexing urticaria problem : present concepts of etiology and management. J Allergy 25:525\u2013560","journal-title":"J Allergy"},{"key":"38_CR2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2133.1969.tb16041.x","volume":"81","author":"RH Champion","year":"1969","unstructured":"Champion RH, Roberts SOB, Carpenter RG, Roger JH (1969) Urticaria and angioedema: a review of 554 patients. Br J Dermatol 81:588\u2013597","journal-title":"Br J Dermatol"},{"key":"38_CR3","doi-asserted-by":"crossref","unstructured":"Zuberbier T, Bindslev-Jensen C, Canonica W et al (2005) EAACI\/GA2LEN\/EDF guideline: definition, classification and diagnosis of urticaria Allergy","DOI":"10.1111\/j.1398-9995.2005.00964.x"},{"key":"38_CR4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2133.1997.tb02140.x","volume":"136","author":"BF O\u2019Donnell","year":"1997","unstructured":"O\u2019Donnell BF, Lawlor F, Simpson J et al (1997) The impact of chronic urticaria on quality of life. Br J Dermatol 136:553\u2013556","journal-title":"Br J Dermatol"},{"key":"38_CR5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0190-9622(99)70495-0","volume":"40","author":"RA Sabroe","year":"1999","unstructured":"Sabroe RA, Seed PT, Francis DM et al (1999) Chronic idiopathic urticaria : comparison of clinical features of patients with and without anti-Fc\u025bR1 or anti-IgE autoantibodies. J Amer Acad Dermatol 40:443\u2013450","journal-title":"J Amer Acad Dermatol"},{"key":"38_CR6","unstructured":"O\u2019Donnell BF, Black AK (1995) Urticarial Vasculitis Int Angiol 14:166\u2013174"},{"key":"38_CR7","volume-title":"Urticaria and Angioedema","author":"AK Black","year":"2004","unstructured":"Black AK (2004) Physical urticarias. In: Greaves MW, Kaplan AP (eds) Urticaria and Angioedema. Marcel Dekker, NY"},{"key":"38_CR8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000235301","volume":"93","author":"CEH Grattan","year":"1990","unstructured":"Grattan CEH, Boon AP, Eady RAJ, Winkelmann RK (1990) The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late phase reactions. Int Arch Allergy Immunol 93:198\u2013204","journal-title":"Int Arch Allergy Immunol"},{"key":"38_CR9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<844::AID-IMMU844>3.0.CO;2-4","volume":"28","author":"P Frandji","year":"1998","unstructured":"Frandji P et al (1998) IL-4 mRNA transcription is induced in mouse bone marrow-derived mast cells through an MHC class11-dependent signaling pathway. Eur J Immunol 28:844\u2013855","journal-title":"Eur J Immunol"},{"key":"38_CR10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2133.1973.tb08014.x","volume":"88","author":"G Michaelsson","year":"1973","unstructured":"Michaelsson G, Juhlin L (1973) Urticaria induced by preservatives and dye additives in food and drugs. Br J Dermatol 88:525\u2013532","journal-title":"Br J Dermatol"},{"key":"38_CR11","first-page":"23","volume":"13","author":"MW Greaves","year":"2001","unstructured":"Greaves MW (2001) Chronic idiopathic urticaria and H pylori: not directly causative but could there be a link? ACI International 13:23\u201326","journal-title":"ACI International"},{"key":"38_CR12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1398-9995.1962.tb02937.x","volume":"17","author":"H Rorsman","year":"1962","unstructured":"Rorsman H (1962) Basophilic leucopenia in different forms of urticaria. Acta Allergologica 17:168\u2013184","journal-title":"Acta Allergologica"},{"key":"38_CR13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0091-6749(89)90180-2","volume":"84","author":"A Leznoff","year":"1989","unstructured":"Leznoff A, Sussman GL (1989) Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 84:66\u201371","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR14","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM199306033282204","volume":"328","author":"M Hide","year":"1993","unstructured":"Hide M, Francis DM, Grattan CEH et al (1993) Autoantibodies against the high affinity IgE receptor as acause for histamine release in chronic urticaria. New Eng J Med 328:1599\u20131604","journal-title":"New Eng J Med"},{"key":"38_CR15","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/1523-1747.ep12338544","volume":"106","author":"N Nimii","year":"1996","unstructured":"Nimii N, Francis DM, Kermani F et al (1996) Dermal mast cell activation by autoantibody against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 106:1001\u20131006","journal-title":"J Invest Dermatol"},{"key":"38_CR16","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1172\/JCI118325","volume":"96","author":"E Fiebiger","year":"1995","unstructured":"Fiebiger E, Maurer D, Holub H et al (1995) Autoantibodies directed against the \u03b1-chain of Fcepsilon R1; a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients. J Clin Invest 96:2606\u20132612","journal-title":"J Clin Invest"},{"key":"38_CR17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0091-6749(97)70071-X","volume":"99","author":"LJ Tong","year":"1997","unstructured":"Tong LJ, Balakrishnan G, Kochan JP et al (1997) Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 99:461\u2013465","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jaci.2004.12.1120","volume":"115","author":"S Soundararajan","year":"2005","unstructured":"Soundararajan S, Kikuchi K, Joseph K, Kaplan AP (2005) Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol 115:815\u2013821","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1172\/JCI511","volume":"101","author":"E Fiebiger","year":"1998","unstructured":"Fiebiger E, Hammaerschmid F, Stingl G, Maurer D (1998) Anti-Fcepsilon R1 autoantibodies in autoimmune-mediated disorders. Identification of a structure function relationship. J Clin Invest 101:243\u2013251","journal-title":"J Clin Invest"},{"key":"38_CR20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0091-6749(99)70129-6","volume":"104","author":"M Ferrer","year":"1999","unstructured":"Ferrer M, Nakazawa K, Kaplan AP (1999) Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 104:169\u2013172","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1067\/mai.2002.120954","volume":"109","author":"Y Kikuchi","year":"2002","unstructured":"Kikuchi Y, Kaplan AP (2002) A role for C5a in augmenting IgG dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 109:114\u2013118","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2222.1974.tb01384.x","volume":"4","author":"MW Greaves","year":"1974","unstructured":"Greaves MW, Plummer VM, McLaughlan P, Stanworth DR (1974) Serum and cell bound IgE in chronic urticaria. Clin Allergy 4:265\u2013271","journal-title":"Clin Allergy"},{"key":"38_CR23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0091-6749(98)70283-0","volume":"102","author":"RA Sabroe","year":"1998","unstructured":"Sabroe RA, Francis DM, Barr RM et al (1998) Anti-Fcepsilon R1 autoantibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 102:651\u2013658","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1067\/mai.2002.121314","volume":"109","author":"R Confino-Cohen","year":"2002","unstructured":"Confino-Cohen R, Aharoni D, Goldberg A et al (2002) Evidence for aberrant regulation of the P21 Ras pathway in PBMCC\u2019s of patients with chronic urticaria. J Allergy Clin Immunol 109:349\u2013356","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2222.1991.tb03198.x","volume":"21","author":"CEH Grattan","year":"1991","unstructured":"Grattan CEH, Francis DM, Hide M, Greaves MW (1991) Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 21:695\u2013704","journal-title":"Clin Exp Allergy"},{"key":"38_CR26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0091-6749(99)70475-6","volume":"103","author":"RA Sabroe","year":"1999","unstructured":"Sabroe RA, Poon E, Orchard GE et al (1999) Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-Fc epsilon R1 or anti-IgE autoantibodies. J Allergy Clin Immunol 103:484\u2013493","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2133.1986.tb04065.x","volume":"114","author":"CEH Grattan","year":"1986","unstructured":"Grattan CEH, Wallington TB, Warin RP et al (1986) A serological mediator in chronic idiopathic urticaria\u2014a clinical immunological and histological evaluation. Br J Dermatol 114:583\u2013590","journal-title":"Br J Dermatol"},{"key":"38_CR28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1365-2133.1999.02707.x","volume":"140","author":"RA Sabroe","year":"1999","unstructured":"Sabroe RA, Grattan CEH, Francis DM et al (1999) The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 140:446\u2013452","journal-title":"Br J Dermatol"},{"key":"38_CR29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1067\/mai.2002.126782","volume":"40","author":"RA Sabroe","year":"2002","unstructured":"Sabroe RA, Fiebiger E, Francis DM et al (2002) Classification of anti-Fc\u025bR1 and anti-IgE autoantibodies in chronic urticaria and correlation with disease activity. J Allergy Clin Immunol 40:492\u2013499","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR30","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1046\/j.1365-2222.2001.01131.x","volume":"31","author":"R Asero","year":"2001","unstructured":"Asero R, Tedeschi A, Lorini M et al (2001) Chronic urticaria: novel clinical and serological aspects. Clin Exp Allergy 31:1105\u20131110","journal-title":"Clin Exp Allergy"},{"key":"38_CR31","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1067\/mjd.2002.122759","volume":"46","author":"CEH Grattan","year":"2002","unstructured":"Grattan CEH, Sabroe RA, Greaves MW (2002) Chronic urticaria. J Amer Acad Dermatol 46:645\u2013657","journal-title":"J Amer Acad Dermatol"},{"key":"38_CR32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00130832-200310000-00008","volume":"3","author":"MW Greaves","year":"2003","unstructured":"Greaves MW (2003) Chronic idiopathic urticaria. Curr Opin Allergy Clin Immunol 3:363\u2013368","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"38_CR33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaci.2004.02.049","volume":"114","author":"AP Kaplan","year":"2004","unstructured":"Kaplan AP (2004) Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 114:465\u2013474","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR34","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1034\/j.1398-9995.2003.00195.x","volume":"58","author":"M Ferrer","year":"2003","unstructured":"Ferrer M, Luquin E, Kaplan AP (2003) IL-3 effect on basophils histamine release upon stimulation with chronic urticaria sera. Allergy 58:802\u2013807","journal-title":"Allergy"},{"key":"38_CR35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0091-6749(96)70230-0","volume":"98","author":"B Zweiman","year":"1996","unstructured":"Zweiman B, Valenzano M, Atkins PC et al (1996) Characteristics of histamine releasing activity in the sera of patients with chronic idiopathic urticaria. J Allergy Clin Immunol 98:89\u201398","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR36","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0091-6749(98)70176-9","volume":"101","author":"M Ferrer","year":"1998","unstructured":"Ferrer M, Kinet JP, Kaplan A (1998) Comparative studies of functional and binding assays for IgG anti-Fc(epsilon) R1 alpha (alpha subunit) in chronic urticaria. J Allergy Clin Immunol 101:672\u2013676","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR37","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1067\/mai.2001.115484","volume":"107","author":"Y Kikuchi","year":"2001","unstructured":"Kikuchi Y, Kaplan AP (2001) Mechanisms of autoimmjune activation of basophils in chronic urticaria. J Allergy Clin Immunol 107:1056\u20131062","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR38","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jaci.2004.07.042","volume":"114","author":"L Brunetti","year":"2004","unstructured":"Brunetti L, Francavilla R, Miniello VL et al (2004) High prevalence of autoimmune urticaria in children with chronic urticaria. J Allergy Clin Immunol 114:922\u2013927","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR39","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1096\/fj.00-0890hyp","volume":"15","author":"MP Horn","year":"2001","unstructured":"Horn MP, Pachlopnik JM, Vogel M et al (2001) Conditional autoimmunity mediated by human natural anti-Fc\u025bR1\u03b1 autoantibodies. FASEB J 15:2268\u20132274","journal-title":"FASEB J"},{"key":"38_CR40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaut.2003.09.007","volume":"22","author":"JM Pachlopnik","year":"2004","unstructured":"Pachlopnik JM, Horn MP, Fux M et al (2004) Natural Fc\u025bR1\u03b1 autoantibodies may interfere with diagnostic tests for chronic urticaria. J Autoimmun 22:43\u201351","journal-title":"J Autoimmun"},{"key":"38_CR41","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1139::AID-IMMU1139>3.0.CO;2-J","volume":"29","author":"MP Horn","year":"1999","unstructured":"Horn MP Gerster T, Ochensberger B et al (1999) Human anti-Fc\u025bR1\u03b1 autoantibodies isolated from healthy donors cross react with tetanus toxoid. Eur J Immunol 29:1139\u20131148","journal-title":"Eur J Immunol"},{"key":"38_CR42","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1067\/mjd.2003.142","volume":"48","author":"MMA Kozel","year":"2003","unstructured":"Kozel MMA, Bossuyt PMM, Mekkes JR et al (2003) Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic review. J Amer Acad Dermatol 48:409-416","journal-title":"J Amer Acad Dermatol"},{"key":"38_CR43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1398-9995.2005.00962.x","volume":"61","author":"T Zuberbier","year":"2006","unstructured":"Zuberbier T, Bindslev-Jensen C, Canonica W et al (2006) EAACI\/GA2LEN\/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 61:321\u2013331","journal-title":"Allergy"},{"key":"38_CR44","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1056\/NEJM197706232962505","volume":"296","author":"NA Soter","year":"1977","unstructured":"Soter NA (1977) Chronic urticaria as a manifestation of necrotizing venulitis. N Eng J Med 296:1440\u20131442","journal-title":"N Eng J Med"},{"key":"38_CR45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.2005.06646.x","volume":"153","author":"BF O\u2019Donnell","year":"2005","unstructured":"O\u2019Donnell BF, Francis DM, Swana GT et al (2005) Thyroid autoimmunity in chronic urticaria. Brit J Dermatol 153:331\u2013335","journal-title":"Brit J Dermatol"},{"key":"38_CR46","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archderm.1983.01650320010007","volume":"119","author":"A Leznoff","year":"1983","unstructured":"Leznoff A, Josse RG, Denberg J, Dolovich J (1983) Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 119:636\u2013640","journal-title":"Arch Dermatol"},{"key":"38_CR47","first-page":"286","volume":"4","author":"AP Kaplan","year":"1999","unstructured":"Kaplan AP, Finn A (1999) Autoimmunity and the etiology of chronic urticaria. Canad J Allergy Clin Immunol 4:286\u2013292","journal-title":"Canad J Allergy Clin Immunol"},{"key":"38_CR48","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000086667","volume":"18","author":"MW Greaves","year":"2005","unstructured":"Greaves MW (2005) Antihistamines in dermatology. Skin Physiol Pharmacol 18:220\u2013229","journal-title":"Skin Physiol Pharmacol"},{"key":"38_CR49","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1081-1206(10)62515-X","volume":"84","author":"HS Nelson","year":"2000","unstructured":"Nelson HS, Reynolds R, Mason J (2000) Fexofenadine HCL is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 84:517\u2013522","journal-title":"Ann Allergy Asthma Immunol"},{"key":"38_CR50","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1067\/mai.2003.63","volume":"111","author":"J Versten","year":"2003","unstructured":"Versten J, Volkerts, ER, Von Ostenwijck AW et al (2003) Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance and mood. J Allergy Clin Immunol 111:623\u2013627","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR51","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/0003-4819-132-5-200003070-00004","volume":"132","author":"J Weiler","year":"2000","unstructured":"Weiler J, Bloom JR, Woodworth GG et al (2000) Effects of fexofenadine, diphenhydramine and alcohol on driving performance. A randomized placebo-controlled trial in the Iowa driving simulator. Ann Int Med 132:354\u2013363","journal-title":"Ann Int Med"},{"key":"38_CR52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2133.1987.tb04095.x","volume":"117","author":"S Bleehen","year":"1987","unstructured":"Bleehen S, Thomas SE, Greaves MW et al (1987) Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double blind study. Br J Dermatol 117:81\u201388","journal-title":"Br J Dermatol"},{"key":"38_CR53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","volume":"312","author":"DL Sackett","year":"1996","unstructured":"Sackett DL, Rosenberg WMC, Gray JA et al (1996) Evidence based medicine: what it is and what it isn\u2019t : its about integrating individual clinical expertise and the best external evidence. Br Med J 312:71\u201372","journal-title":"Br Med J"},{"key":"38_CR54","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0091-6749(98)70032-6","volume":"102","author":"MH Ellis","year":"1998","unstructured":"Ellis MH (1998) Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol 102:876\u2013877","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaci.2003.10.002","volume":"113","author":"SE Bagenstose","year":"2004","unstructured":"Bagenstose SE, Levin L, Bernstein JA (2004) The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol 113:134\u2013140","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR56","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1046\/j.1365-2222.2001.01189.x","volume":"31","author":"ML Pacor","year":"2001","unstructured":"Pacor ML, Di Lorenzo G, Corrocher R (2001) Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and\/or salicylic acid. Clin Exp Allergy 31:1607\u20131614","journal-title":"Clin Exp Allergy"},{"key":"38_CR57","first-page":"99","volume":"137","author":"E Nettis","year":"2001","unstructured":"Nettis E, Dambra P, D\u2019Oronzio L et al (2001) Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Arch Dermatol 137:99\u2013100","journal-title":"Arch Dermatol"},{"key":"38_CR58","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1067\/mai.2001.120275","volume":"108","author":"C Perez","year":"2001","unstructured":"Perez C, Sanchez-Borges M (2001) Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema. J Allergy Clin Immunol 108:1060\u20131061","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR59","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1067\/mai.2002.126676","volume":"110","author":"Z Erbagci","year":"2002","unstructured":"Erbagci Z (2002) The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind placebo-controlled crossover. J Allergy Clin Immunol 110:484\u2013488","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR60","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaci.2004.06.018","volume":"114","author":"G Lorenzo Di","year":"2004","unstructured":"Di Lorenzo G, Pacor ML, Mansueto P et al (2004) Randomised placebo- controlled trial comparing desloratidine and montelukast in monotherapy and deslotatidine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol 114:619\u2013625","journal-title":"J Allergy Clin Immunol"},{"key":"38_CR61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.279.6.455","volume":"279","author":"ME Wechsler","year":"1998","unstructured":"Wechsler ME, Garbpestad E, Flier SR et al (1998) Pulmonary infiltrates, eosinophilia and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. J Amer Med Ass 279:455\u2013457","journal-title":"J Amer Med Ass"},{"key":"38_CR62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJMcp011186","volume":"346","author":"AP Kaplan","year":"2002","unstructured":"Kaplan AP (2002) Chronic urticaria and angioedema. New Eng J Med 346:175\u2013179","journal-title":"New Eng J Med"},{"key":"38_CR63","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2133.1987.tb05877.x","volume":"116","author":"E Wong","year":"1987","unstructured":"Wong E, Eftekhari N, Greaves MW, Milford Ward A (1987) Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria. Br J Dermatol 116:553\u2013556","journal-title":"Br J Dermatol"},{"key":"38_CR64","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1346-8138.2001.tb00137.x","volume":"28","author":"D Parsad","year":"2001","unstructured":"Parsad D, Pandhi R, Juneja A (2001) Stanozolol in chronic urticaria: results of a double blind placebo controlled trial. J Dermatol 28:299\u2013302","journal-title":"J Dermatol"},{"key":"38_CR65","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaad.2004.09.023","volume":"52","author":"A Kessel","year":"2005","unstructured":"Kessel A, Bamberger E, Toubi E (2005) Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open label prospective study. J Amer Acad Dermatol 52:145\u2013148","journal-title":"J Amer Acad Dermatol"},{"key":"38_CR66","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.2000.03664.x","volume":"143","author":"CEH Grattan","year":"2000","unstructured":"Grattan CEH, O\u2019Donnell BF, Francis DM et al (2000) Randomised double blind study of cyclosporine in chronic idiopathic urticaria. Br J Dermatol 143:365\u2013372","journal-title":"Br J Dermatol"},{"key":"38_CR67","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1365-2133.1998.02033.x","volume":"138","author":"BF O\u2019Donnell","year":"1998","unstructured":"O\u2019Donnell BF, Barr RM, Black AK et al (1998) Intravenous immunoglobulin in chronic urticaria. Br J Dermatol 138:101\u2013106","journal-title":"Br J Dermatol"},{"key":"38_CR68","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/0140-6736(92)90666-Q","volume":"339","author":"CEH Grattan","year":"1992","unstructured":"Grattan CEH, Francis DM, Slater NGP et al (1992) Plasmapheresis for severe unremitting chronic urticaria. Lancet 339:1078\u20131080","journal-title":"Lancet"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-0038-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-007-0038-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-0038-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:48:38Z","timestamp":1559440118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-007-0038-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,18]]},"references-count":68,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s12016-007-0038-3","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,18]]}}}